Skip to content
Open access

STEM-03 POU3F3 Drives a Glial Progenitor-like State Preferentially Coopted in Glioblastoma

Nov 2026 · Neuro-Oncology · 0 citations

Abstract

Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults, characterized by rapid progression, marked cellular heterogeneity, invasive growth, and poor prognosis. GBM cells exhibit adaptive, stem cell-like plasticity, in part through aberrant activation of oncofetal signaling pathways and epigenetic programs normally active only during brain development. As a result, efforts have increasingly focused on identifying parallels between GBM and neurodevelopment to uncover new therapeutic vulnerabilities. We generated a new multi-omic atlas of human cortical neurodevelopment, composed of matched single nucleus (sn) RNA-seq and snATAC-seq data from germinal matrix and cortical plate spanning second trimester to infancy, and used it to identify developmental cell states reactivated in GBM. Functional validation studies included siRNA-mediated knockdown to assess effects on GBM viability, proliferation, stem-like properties, and migration in primary patient-derived cell lines. Integrated multi-omic analysis uncovered a conserved oncofetal program enriched across GBM subtypes, regions, and primary/recurrence status, recapitulating gliogenic intermediate progenitor cell (gIPC)-like state, normally seen only transiently during late prenatal development. Gene regulatory network analysis identified POU3F3 as a central regulator of the gIPC-like state in GBM and prioritized a putative enhancer binding site upstream of EGFR. Knockdown of POU3F3 resulted in significantly decreased GBM stem cell-like frequency, tumor proliferation, gliomasphere migration, and EGFR expression. Moreover, pharmacologic inhibition of POU3F3 with Rosarin showed synergistic anti-proliferative effects in combination with the standard-of-care chemotherapeutic Temozolomide, highlighting POU3F3 as a promising therapeutic target in GBM. Our study identifies POU3F3 as a central regulator of the gIPC-like stem/progenitor state in GBM sustaining tumor plasticity through EGFR and revealing a developmentally co-opted oncofetal regulatory axis that drives glioblastoma progression. These findings not only provide a developmental chromatin framework for understanding gliogenic programs but also nominate POU3F3 and related oncofetal transcriptional regulators as promising therapeutic targets in GBM.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.